Inventor

TENG MIN

US102 patents

⚠️ This page may combine multiple inventors who share the name “TENG MIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TENG MIN

ALLERGAN INC

N-aryl substituted tetrahydroquinolines having retinoid agonist, retinoid antagonist or retinoid inverse agonist type biological activity

Substituted heteroarylamides having retinoid-like biological activity

Methods of treatment with compounds having RARα receptor specific or selective activity

Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity

Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

Tetrahydronaphthalene derivatives substituted in the 8 position with alkyhidene groups having retinoid and/or retinoid antagonist-like biological activity

Oxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4,-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity

Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity

Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity

Substituted acetylenes having retinoid-like biological activity

Acetylenes disubstituted with a 5 substituted dihydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity

Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity

Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl of heteroaryl group having retinoid-like biological activity

Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity

Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity

Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity

Acetylenes disubstituted with a 5 OXO substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity

Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-thio-1,2,3,4-tetrahdroquinolinyl, 2-alkylthio-3,4-dihydroquinolinyl or 2-alkoxy-3,4-dihydroquinolinyl group having retinoid-like biological activity

Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

Aryl-and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity

O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity

(3&#34;-thioxacyclohex-1&#34;-enyl)!-but-3&#39;-ene-1&#39;-ynyl!aryl and (3&#34;-thioxacyclohex-1&#34;-enyl)!-but-3&#39;-ene-1&#39;-ynyl!heteroaryl carboxylic acids and esters having retinoid-like biological activity

ALLERGAN SALES INC

Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity

Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity

Trisubstituted phenyl derivatives having retinoid agonist or inverse agonist type biological activity

Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity

Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity

Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

Methods of treatment with compounds having RARα receptor specific or selective activity

O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist like biological activity

Substituted aryl or heteroarylamides having retinoid-like biological activity

(unassigned)

Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological

Disubstituted aryl and heteroaryl imines having retinoid-like biological activity

Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

Alkylidene substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

AGOURON PHARMA

Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use

Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use

NOVO NORDISK AS

Glucagon antagonists/inverse agonists

PURDUE RESEARCH FOUNDATION

Optical coupler having exposed subwavelength gratings for coupling electromagnetic field

(3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!aryl and (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!heteroaryl carboxylic acids and esters having retinoid-like biological activity